Dr. Fauci Thinks US Will Have ‘Herd Immunity’ , by Late Spring or Early Summer. As the Pfizer-BioNTech vaccine starts to roll out in America, Fauci thinks the country can achieve heard immunity by “the end of the second quarter 2021.”. If enough people make the decision to get vaccinated. it could be “sometime by the end of March, the beginning of April, that the normal healthy man and woman in the street who has no underlying conditions would likely get it.”. By the time we get to the fall, we can start approaching some degree of relief where the level of infection will be so low in society we can start essentially approaching some form of normality, Dr. Anthony Fauci, to MSNBC’s Hallie Jackson. Dr. Fauci also said it will still likely be necessary to wear masks, postpone public events . and continue detailed hygiene protocols “several months into the second half and beyond of 2021.”. Only when you get the level of infection in society so low that it’s no longer a public health threat can you then think about the possibility of then pulling back on public health measures, Dr. Anthony Fauci, to MSNBC’s Hallie Jackson. Dr. Fauci intends to be publicly vaccinated as soon as possible to encourage people “that this is something we should do.”
By Tim Darnell
Despite recent case declines and more vaccinations, coronavirus deaths and cases per day in the U.S. are still running at high levels, and President Joe Biden’s chief medical adviser is urging Americans to remain vigilant and keep practicing social distancing.
Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said the improvement in numbers around the country appears to reflect a “natural peaking and then plateauing” after a holiday surge, rather than the arrival of the vaccine in mid-December.
“I don’t think the dynamics of what we’re seeing now with the plateauing is significantly influenced yet — it will be soon — but yet by the vaccine. I just think it’s the natural course of plateauing,” Fauci told NBC’s “Today” earlier this week.
Fauci, according to BGR, is still recommending Americans avoid indoor gatherings, gyms, bars and restaurants. He also continues recommending against travel.
The U.S. is recording just under 3,100 deaths a day on average, down from more than 3,350 less than two weeks ago. New cases are averaging about 170,000 a day after peaking at almost 250,000 on Jan. 11. The number of hospitalized COVID-19 patients has fallen to about 110,000 from a high of 132,000 on Jan. 7.
Nationwide, about 19.3 million people, or less than 6% of the U.S. population, have received at least one dose of the vaccine, including about 3 million who have gotten the second shot, according to the Atlanta-based Centers for Disease Control and Prevention. About 55% of the 41 million doses distributed to the states by the federal government have been injected into arms, by the CDC’s count.
The virus has killed more than 425,000 Americans and infected more than 25 million, according to Johns Hopkins University. Earlier this month, the CDC estimated the U.S. coronavirus death toll to rise to more than 500,000 by mid-February.
Health experts have warned the more contagious and possibly more deadly variant sweeping through Britain will probably become the dominant source of infection in the U.S. by March. It has been reported in more than 20 states so far. Other mutant versions are circulating in South Africa and Brazil. The variant from Brazil was detected for the first time in the U.S. in a Minnesota resident who recently traveled to the South American country, state health officials said Monday.
To guard against the new variants, Biden on Monday added South Africa to the list of more than two dozen countries whose residents are subject to coronavirus-related limits on entering the U.S.
Fauci said scientists are already preparing to adjust COVID-19 vaccines to fight the mutated versions. He said there is “a very slight, modest diminution” of the effectiveness of COVID-19 vaccines against those variants, but “there’s enough cushion with the vaccines that we have that we still consider them to be effective” against both.
Moderna, the maker of one of the two vaccines being used in the U.S., announced on Monday it is beginning to test a possible booster dose against the South African variant. Moderna CEO Stephane Bancel said the move was out of “an abundance of caution” after preliminary lab tests suggested its shot produced a weaker immune response to that variant.
The vaccine rollout in the U.S. has been marked by disarray and confusion, with states complaining in recent days about shortages and inadequate deliveries that have forced them to cancel mass vaccination events and tens of thousands of appointments.
The Associated Press contributed to this report.
Read the original story on AJC.com.
